Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
28 hedge funds and large institutions have $44.2M invested in Apollo Endosurgery, Inc. in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 4 closing their positions.
225% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 4
135% more capital invested
Capital invested by funds: $18.8M → $44.2M (+$25.4M)
7% less funds holding
Funds holding: 30 → 28 (-2)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.37M |
| 2 |
GS
Gagnon Securities
New York
|
+$1.08M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$988K |
| 4 |
Goldman Sachs
New York
|
+$833K |
| 5 |
GA
Gagnon Advisors
New York
|
+$740K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Austin,
Texas
|
-$694K |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
-$469K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$107K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$89K |
| 5 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$76K |
APEN Hedge Fund Activity: Q4 2020 in Review
28 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q4 2020, worth a combined $44.2M — up 135% from $18.8M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of APEN and 3 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 13 added.
The largest buyer was Stonepine Capital Management, adding an estimated $2.37M. The largest seller was University of Texas/Texas AM Investment Management Co (UTIMCO), cutting an estimated $694K.
- 28 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q4 2020, down from 30 in Q3 2020.
- Funds reported $44.2M of Apollo Endosurgery, Inc. stock for Q4 2020, up 135% quarter-over-quarter.
- 3 funds opened new Apollo Endosurgery, Inc. positions in Q4 2020 and 4 closed out, a net change of -1 holder.
- The largest Apollo Endosurgery, Inc. buyer in Q4 2020 was Stonepine Capital Management, an estimated $2.37M added.
- The largest Apollo Endosurgery, Inc. seller in Q4 2020 was University of Texas/Texas AM Investment Management Co (UTIMCO), an estimated $694K sold.
Based on aggregated 13F filings for Q4 2020.